V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20212943 | 20178107 | 1.57 | 96 | Palliative (P) | 2021-10-16 | 2022-01-19 | CISPLATIN + GEMCITABINE | 02 | N | CISPLATIN + GEMCITABINE | 100245207 |
| 20212995 | 20178108 | 1.58 | 77 | null | 2020-08-19 | 2020-08-25 | CAPECITABINE + IRINOTECAN | 02 | null | CAPECITABINE + IRINOTECAN | 100296693 |
| 20213000 | 20178109 | 1.48 | 100.6 | Palliative (P) | 2017-03-06 | 2017-03-16 | CISPLATIN + GEMCITABINE | 02 | N | CISPLATIN + GEMCITABINE | 101800398 |
| 20213001 | 20178110 | 1.71 | 65.8 | Palliative (P) | 2021-05-25 | 2021-06-27 | Capecitabine (14 day) + Irinotecan | 02 | N | CAPECITABINE + IRINOTECAN | 101608794 |
| 20213023 | 20178111 | 1.77 | 76.1 | null | 2021-11-30 | 2022-02-09 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | null | CISPLATIN + GEMCITABINE | 101298531 |
| 20213039 | 20178112 | 1.5 | 60.9 | Palliative (P) | 2018-06-07 | 2018-07-20 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | CISPLATIN + GEMCITABINE | 101150775 |
| 20213045 | 20178113 | 1.65 | 66.1 | Palliative (P) | 2021-07-16 | 2021-07-16 | Capecitabine (21 day) + Irinotecan | 02 | N | CAPECITABINE + IRINOTECAN | 100417278 |
| 20213046 | 20178114 | 1.54 | 78 | Palliative (P) | 2020-12-25 | 2021-01-10 | Capecitabine (14 day) + Irinotecan | 02 | N | CAPECITABINE + IRINOTECAN | 100763023 |
| 20213074 | 20178116 | 1.93 | 79.9 | Palliative (P) | 2021-01-24 | 2021-01-28 | Capecitabine (21 day) + Irinotecan | N | N | CAPECITABINE + IRINOTECAN | 100519227 |
| 20213126 | 20178117 | 1.76 | 70 | null | 2021-07-20 | 2021-08-01 | Capecitabine (14 day) + Irinotecan | N | null | CAPECITABINE + IRINOTECAN | 100450167 |
| 20213130 | 20178118 | 1.57 | 98 | Palliative (P) | 2019-09-26 | 2019-10-29 | Capecitabine (21 day) + Irinotecan | 02 | N | CAPECITABINE + IRINOTECAN | 101518676 |
| 20213158 | 20178120 | 1.53 | 72 | Palliative (P) | 2016-06-09 | 2016-06-22 | Capecitabine (21 day) + Irinotecan | 02 | N | CAPECITABINE + IRINOTECAN | 101325699 |
| 20213160 | 20178121 | 1.57 | 129.1 | Palliative (P) | 2022-02-28 | 2022-03-12 | Capecitabine (21 day) + Irinotecan | 02 | N | CAPECITABINE + IRINOTECAN | 100933067 |
| 20213168 | 20178122 | 1.55 | 77 | Palliative (P) | 2017-09-12 | 2017-12-02 | Capecitabine (14 day) + Irinotecan | 02 | N | CAPECITABINE + IRINOTECAN | 101783672 |
| 20213171 | 20178123 | 1.78 | 57.6 | Palliative (P) | 2016-09-20 | 2016-10-04 | CISPLATIN + GEMCITABINE | 02 | N | CISPLATIN + GEMCITABINE | 100737345 |
| 20213196 | 20178124 | 1.85 | 79 | Palliative (P) | 2021-08-29 | 2021-11-08 | Capecitabine (21 day) + Irinotecan | 02 | N | CAPECITABINE + IRINOTECAN | 101858089 |
| 20213298 | 20178127 | 1.52 | 67.5 | Palliative (P) | 2021-10-01 | 2021-10-03 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | CISPLATIN + GEMCITABINE | 101746436 |
| 20213305 | 20178128 | 1.7 | 78 | null | 2016-12-17 | 2017-01-02 | Capecitabine (14 day) + Irinotecan | 02 | null | CAPECITABINE + IRINOTECAN | 100266986 |
| 20213316 | 20178129 | 1.7 | 67 | Palliative (P) | 2017-11-05 | 2018-12-16 | Capecitabine (21 day) + Irinotecan | 02 | N | CAPECITABINE + IRINOTECAN | 100094673 |
| 20213320 | 20178130 | 1.59 | 44.8 | null | 2021-10-26 | 2021-10-26 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101384205 |
| 20213323 | 20178131 | 1.53 | 55.4 | null | null | 2022-04-28 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CAPECITABINE + GEMCITABINE | 101170129 |
| 20213344 | 20178132 | 1.88 | 68.8 | Palliative (P) | 2017-10-17 | 2017-11-04 | Docetaxel 100mg/m2 (21 day) | 02 | null | DOCETAXEL | 100499929 |
| 20213356 | 20178133 | 1.55 | 60.8 | null | 2022-03-26 | 2022-03-26 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100940057 |
| 20213363 | 20178134 | 1.74 | 83 | null | 2019-01-26 | 2019-02-10 | CETUXIMAB + IRINOTECAN + MDG | 2 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101627681 |
| 20213373 | 20178135 | 1.66 | 62.7 | null | 2018-09-11 | 2018-09-19 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100234632 |
| 20213398 | 20178137 | 1.62 | 91.4 | null | null | 2018-05-05 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100769443 |
| 20213402 | 20178138 | 1.97 | 64.7 | null | 2020-11-06 | 2021-01-02 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101523000 |
| 20213454 | 20178139 | 1.59 | 80.3 | Adjuvant (A) | 2021-09-01 | 2021-09-12 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100597527 |
| 20213460 | 20178140 | 1.68 | 65 | Palliative (P) | 2021-05-01 | 2021-05-15 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101821807 |
| 20213486 | 20178141 | 1.67 | 46.6 | Palliative (P) | 2021-06-06 | 2021-06-07 | Docetaxel | 02 | N | DOCETAXEL | 100307024 |
| 20213502 | 20178142 | 1.69 | 74.7 | null | 2019-07-30 | 2019-08-11 | Cetuximab + FOLFIRI cycle 2 onwards | N | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101743604 |
| 20213512 | 20178143 | 1.76 | 56.8 | Palliative (P) | null | 2018-06-19 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100838171 |
| 20213527 | 20178144 | 1.61 | 65.6 | Adjuvant (A) | 2020-11-05 | 2020-12-11 | Cetuximab + FLUOROURACIL + IRINOTECAN | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100627442 |
| 20213551 | 20178145 | 1.69 | 70.15 | Curative (C) | 2018-07-19 | 2019-02-05 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101547047 |
| 20213576 | 20178147 | 1.67 | 71 | Palliative (P) | 2021-11-19 | 2021-11-19 | Docetaxel | 02 | N | DOCETAXEL | 101242007 |
| 20213577 | 20178148 | 1.85 | 62.2 | null | 2018-05-24 | 2018-06-02 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100439753 |
| 20213597 | 20178149 | 1.74 | 87.8 | null | 2020-10-16 | 2020-10-16 | Docetaxel | 02 | null | DOCETAXEL | 101514056 |
| 20213602 | 20178150 | 1.63 | 58.6 | Palliative (P) | 2020-02-17 | 2020-02-17 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 100019214 |
| 20213605 | 20178151 | 1.69 | 91.2 | Adjuvant (A) | 2020-06-20 | 2020-07-04 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101414041 |
| 20213617 | 20178152 | 1.66 | 50.2 | Palliative (P) | 2021-12-30 | 2022-04-16 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101858310 |
| 20213630 | 20178153 | 1.8 | 134.8 | Palliative (P) | 2020-02-14 | 2020-02-28 | Docetaxel | 02 | N | DOCETAXEL | 101757802 |
| 20213641 | 20178154 | 1.8 | 71 | Palliative (P) | 2017-09-23 | 2017-09-23 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100082249 |
| 20213650 | 20178155 | 1.76 | 74.6 | null | 2020-02-22 | 2020-03-01 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100907422 |
| 20213673 | 20178156 | 1.53 | 95 | Palliative (P) | 2017-03-28 | 2017-04-25 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101288605 |
| 20213691 | 20178157 | 1.59 | 62.85 | 03 | 2021-03-07 | 2021-03-21 | Docetaxel | 02 | N | DOCETAXEL | 100447855 |
| 20213717 | 20178158 | 1.74 | 0 | Adjuvant (A) | 2021-10-08 | 2021-10-20 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101017893 |
| 20213723 | 20178159 | null | 79.9 | Palliative (P) | 2021-09-27 | 2021-10-11 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CAPECITABINE + GEMCITABINE | 100344167 |
| 20213734 | 20178160 | 1.65 | 73.9 | null | 2021-10-22 | 2021-11-21 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101426541 |
| 20213748 | 20178161 | 1.68 | 81 | null | 2022-01-01 | 2022-03-22 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101130980 |
| 20213772 | 20178162 | 1.6 | null | Neo-adjuvant (N) | 2020-09-12 | 2020-09-13 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101779967 |